Stage III Intrahepatic Cholangiocarcinoma: Clinical Trials

4 trials for Stage III Intrahepatic Cholangiocarcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 withdrawn, 1 completed, 1 terminated. 3 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 13Withdrawn 2, Completed 1
Phase 31Terminated 1

Follow Stage III Intrahepatic Cholangiocarcinoma: new trials by email Literature Review of Stage III Intrahepatic Cholangiocarcinoma trials Research Report on Stage III Intrahepatic Cholangiocarcinoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ricolinostat, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable or Metastatic Cholangiocarcinoma
Cisplatin, Gemcitabine Hydrochloride, Laboratory Biomarker Analysis - Non-Resectable Cholangiocarcinoma, Recurrent Cholangiocarcinoma
Phase 1WithdrawnMayo Clinic2017-05-012017-05-30
Capecitabine and Y-90 Radioembolization in Treating Patients With Advanced Bile Duct Cancer in the Liver That Cannot Be Removed by Surgery
Capecitabine, Laboratory Biomarker Analysis, Radioembolization - Bile Duct Adenocarcinoma, Stage III Intrahepatic Cholangiocarcinoma
Phase 1WithdrawnCity of Hope Medical Center2016-12-012017-04-18
Radiation Therapy vs. Observation Following Gemcitabine and Cisplatin for Inoperable Localized Liver Cancer
Image Guided Radiation Therapy - Stage III Intrahepatic Cholangiocarcinoma, Stage IVA Intrahepatic Cholangiocarcinoma
Phase 3TerminatedNRG Oncology12014-09-292026-07-13
ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer
ADH-1, Cisplatin, Gemcitabine Hydrochloride - Ampulla of Vater Adenocarcinoma, Gallbladder Adenocarcinoma
Phase 1CompletedUniversity of Nebraska172013-04-092023-12-28

Narrower conditions

Cholangiocarcinoma (4)  ·  Klatskin Tumor (2)  ·  Bile Duct Neoplasms (1)  ·  Gallbladder Neoplasms (1)  ·  Pancreatic Neoplasms (1)

Broader conditions

Adenocarcinoma (4)  ·  Carcinoma (4)  ·  Neoplasms (4)  ·  Neoplasms by Histologic Type (4)  ·  Neoplasms, Glandular and Epithelial (4)  ·  Biliary Tract Diseases (2)  ·  Biliary Tract Neoplasms (2)  ·  Digestive System Diseases (2)  ·  Digestive System Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Bile Duct Diseases (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Gallbladder Diseases (1)  ·  Pancreatic Diseases (1)

Interventions

1,2-diaminocyclohexaneplatinum II citrate (2)  ·  Cisplatin (2)  ·  Gemcitabine (2)  ·  Platinum (2)  ·  Capecitabine (1)  ·  N-Ac-CHAVC-NH2 (1)  ·  Radiotherapy, Image-Guided (1)  ·  ricolinostat (1)

Sponsors

City of Hope Medical Center (1)  ·  Mayo Clinic (1)  ·  NRG Oncology (1)  ·  University of Nebraska (1)

Countries

United States (4)  ·  Canada (1)

Top investigators

Jean L Grem, MD (1)  ·  Jonathan Kessler, MD (1)  ·  Kabir Mody (1)  ·  Theodore Hong (1)

Results publications

PMID 26503201

NIH funding

P30CA015083 (1), P30CA036727 (1), P50CA127297 (1), U10CA180868 (1)